113,57 €
126,19 €
-10% with code: EXTRA
Valproate
Valproate
113,57
126,19 €
  • We will send in 10–14 business days.
Since the fortuitous discovery of its anticonvulsant activIty in 1962, valproate has established itself worldwide as a major antiepileptic drug against several types of epileptic seizures. Clinical experience with valpro- ate has continued to grow in recent years, including use of valproate for diseases other than epilepsy, for example in bipolar disorders and migraine. In this volume on valproate emphasis is placed on the scientific back- ground leading to the discovery of val pro ate, its sub…
  • Publisher:
  • Year: 2012
  • Pages: 286
  • ISBN-10: 3034897618
  • ISBN-13: 9783034897617
  • Format: 17 x 24.4 x 1.7 cm, softcover
  • Language: English
  • SAVE -10% with code: EXTRA

Valproate (e-book) (used book) | bookbook.eu

Reviews

(3.00 Goodreads rating)

Description

Since the fortuitous discovery of its anticonvulsant activIty in 1962, valproate has established itself worldwide as a major antiepileptic drug against several types of epileptic seizures. Clinical experience with valpro- ate has continued to grow in recent years, including use of valproate for diseases other than epilepsy, for example in bipolar disorders and migraine. In this volume on valproate emphasis is placed on the scientific back- ground leading to the discovery of val pro ate, its subsequent pharmacologi- cal and toxicological characterization, and its clinical development into one of the most widely and successfully used anti epileptic drugs, a real mile- stone in drug therapy. The current state of knowledge of valproate will be reviewed by experts in the field, including new hypotheses about its mecha- nisms of action, its metabolism into pharmacologically active metabolites, its unique distribution characteristics, its unwanted hepatotoxic and terato- genic adverse effects and its various clinical uses. Furthermore, the wide variety of available pharmaceutical formulations of valproate, including novel controlled-release formulations, will be outlined. The monograph is aimed at a broad readership, particularly neurologists, psychiatrists and basic scientists working in the field of epilepsy research. Because the monograph also deals with structure-activity relationships of valproate as well as of its metabolites and analogs, the book should also serve for rese- archers working in medicinal chemistry, particularly in the pharmaceutical industry.

EXTRA 10 % discount with code: EXTRA

113,57
126,19 €
We will send in 10–14 business days.

The promotion ends in 20d.16:55:04

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 1,26 Book Euros!?
  • Publisher:
  • Year: 2012
  • Pages: 286
  • ISBN-10: 3034897618
  • ISBN-13: 9783034897617
  • Format: 17 x 24.4 x 1.7 cm, softcover
  • Language: English English

Since the fortuitous discovery of its anticonvulsant activIty in 1962, valproate has established itself worldwide as a major antiepileptic drug against several types of epileptic seizures. Clinical experience with valpro- ate has continued to grow in recent years, including use of valproate for diseases other than epilepsy, for example in bipolar disorders and migraine. In this volume on valproate emphasis is placed on the scientific back- ground leading to the discovery of val pro ate, its subsequent pharmacologi- cal and toxicological characterization, and its clinical development into one of the most widely and successfully used anti epileptic drugs, a real mile- stone in drug therapy. The current state of knowledge of valproate will be reviewed by experts in the field, including new hypotheses about its mecha- nisms of action, its metabolism into pharmacologically active metabolites, its unique distribution characteristics, its unwanted hepatotoxic and terato- genic adverse effects and its various clinical uses. Furthermore, the wide variety of available pharmaceutical formulations of valproate, including novel controlled-release formulations, will be outlined. The monograph is aimed at a broad readership, particularly neurologists, psychiatrists and basic scientists working in the field of epilepsy research. Because the monograph also deals with structure-activity relationships of valproate as well as of its metabolites and analogs, the book should also serve for rese- archers working in medicinal chemistry, particularly in the pharmaceutical industry.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)